Replies to post #327419 on Anavex Life Sciences Corp (AVXL)

[Bourbon_on_my_cornflakes]

NO: Do you own SAVA? I don't know much about it, never bothered to research it. At current prices it's tempting, but there's still an overhanging element of risk

SAVA has been a trader's play. I am a terrible trader. But I watch the swings in it with admiration for those who can trade well. Most of my AVXL position was purchased under $2 a share...that's my style. Will sleep well when it firmly crosses $50 a share.

Today's hit job on SAVA was so obvious, no one here should give it any credit. Held for the moment that SAVA announced the SPA

I still maintain AVXL should merge with SAVA if their drugs complement each other. Even if they don't, there is real potential in its blood test.

Well if we had a proper valuation, we could buy them. But would have to give too much away at this deep undervaluation.

[RedShoulder]

I still maintain AVXL should merge with SAVA if their drugs complement each other.

Why, since 2-73 works up stream from Simufilim, their dug will not be needed and redundant.

A2-73 brings the system into homeostasis upstream, no need for 'fixes' downstream.

Not going to happen.